Arkolith/Insider Trading/AADI/Form 4

Desai Neil

Executive Chairman, Director, 10% OwnerAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Apr 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$87K
Net Open-Market Flow
-$87K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 6, 2023Sell(S)12K$7.09$87K1.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-023692) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML